142 related articles for article (PubMed ID: 6126105)
21. Effect of beta adrenergic blocking agents on erythropoiesis in rats.
Zivný J; Ostádal B; Neuwirt J; Procházka J; Pelouch V
J Pharmacol Exp Ther; 1983 Jul; 226(1):222-5. PubMed ID: 6134822
[TBL] [Abstract][Full Text] [Related]
22. The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
Nosál R; Jancinová V; Ondrias K; Jakubovský J; Balgavý P
Biochim Biophys Acta; 1985 Dec; 821(2):217-28. PubMed ID: 2865973
[TBL] [Abstract][Full Text] [Related]
23. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
Leonhardt U; Nürnberger H; Femmer K
Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
[No Abstract] [Full Text] [Related]
24. Differentiation of metabolic adrenoceptors.
Loakpradit T; Lockwood R
Br J Pharmacol; 1977 Jan; 59(1):135-40. PubMed ID: 13899
[TBL] [Abstract][Full Text] [Related]
25. [The effect of propranolol and metipranolol on systolic time intervals in health volunteers].
Smíd J; Cepelák V; Mayer O
Vnitr Lek; 1981 Jul; 27(7):683-90. PubMed ID: 6117982
[No Abstract] [Full Text] [Related]
26. The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.
Harry JD; Linden RJ; Snow HM
Br J Pharmacol; 1974 Oct; 52(2):275-81. PubMed ID: 4155991
[TBL] [Abstract][Full Text] [Related]
27. The effect of isoprenaline, propranolol and alprenolol on the glycogen phosphorylase activity and glycogen level of the heart of neonate and adult rats.
Brus R
Pol J Pharmacol Pharm; 1973; 25(5):423-8. PubMed ID: 4777345
[No Abstract] [Full Text] [Related]
28. The effect propranolol, alprenolol and practolol on the vibrinolytic and factor VIII responses to adrenaline and salbutamol in man.
Gader AM; Da Costa J; Cash JD
Thromb Res; 1974 Jan; 4(1):25-33. PubMed ID: 4829668
[No Abstract] [Full Text] [Related]
29. Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.
Lochan R; Silke B; Taylor SH
Br J Clin Pharmacol; 1981 Nov; 12(5):721-4. PubMed ID: 6120711
[TBL] [Abstract][Full Text] [Related]
30. Changes in cardiac output, induced by metipranolol and other beta-blockers, in dogs.
Helfert I; Vanĕcek M; Trcka V
Acta Univ Carol Med (Praha); 1980; 26(7-8):345-9. PubMed ID: 6126107
[No Abstract] [Full Text] [Related]
31. [Effect of metipranolol and other blockaders of beta-receptors in experimental animals and man].
Mayer O; Trcka V
Cas Lek Cesk; 1982 Sep; 121(34-35):1083-6. PubMed ID: 6127161
[No Abstract] [Full Text] [Related]
32. [The effect of adrenergic beta receptor blockers on phospholipid metabolism in mast cells].
Pecivová J; Drábiková K; Nosál' R
Bratisl Lek Listy; 1990 May; 91(5):363-8. PubMed ID: 1974476
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
Békés M; Matos L; Rausch J; Török E
Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774
[No Abstract] [Full Text] [Related]
34. Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats.
Shibouta Y; Nishikawa K; Kikuchi S; Shimamoto K
Eur J Pharmacol; 1979 Jan; 53(2):201-8. PubMed ID: 759198
[TBL] [Abstract][Full Text] [Related]
35. Antiaggregatory Properties of Beta-adrenoceptor Blocking Drugs are Related to their Physico-chemical Properties.
Nosál R; Jancinová V; Petriková M
Platelets; 1992; 3(1):29-33. PubMed ID: 21043897
[TBL] [Abstract][Full Text] [Related]
36. [The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol].
Hata T; Kita T; Itoh E; Harada N
Nihon Yakurigaku Zasshi; 1984 May; 83(5):413-24. PubMed ID: 6381261
[TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
Bekes M; Matos L; Rausch J; Török E
Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
[No Abstract] [Full Text] [Related]
38. On the role of the adrenergic receptors for extraneuronal amine uptake and retention in rat salivary glands in vitro.
Almgren O; Jonason J
Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(1):21-35. PubMed ID: 4152983
[No Abstract] [Full Text] [Related]
39. Analysis of the vasodilator action of alprenolol.
Himori N; Izumi A; Ishimori T
Eur J Pharmacol; 1978 Feb; 47(3):341-50. PubMed ID: 631185
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous motor activity in rats given repeatedly beta-sympatholytics, propranolol and trimepranol.
Tikal K; Hvizdosová J; Pavlovicová E
Act Nerv Super (Praha); 1980 Mar; 22(1):71-2. PubMed ID: 6104410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
